| Year |
Citation |
Score |
| 2019 |
Bagwell CB, Hunsberger B, Hill B, Herbert D, Bray C, Selvanantham T, Li S, Villasboas JC, Pavelko K, Strausbauch M, Rahman A, Kelly G, Asgharzadeh S, Gomez-Cabrero A, Behbehani G, ... ... Goldberger O, et al. Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system. Cytometry. Part B, Clinical Cytometry. PMID 31758746 DOI: 10.1002/Cyto.B.21858 |
0.318 |
|
| 2015 |
Kattah NH, Newell EW, Jarrell JA, Chu AD, Xie J, Kattah MG, Goldberger O, Ye J, Chakravarty EF, Davis MM, Utz PJ. Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease. Proceedings of the National Academy of Sciences of the United States of America. 112: 3044-9. PMID 25713364 DOI: 10.1073/Pnas.1424796112 |
0.408 |
|
| 2011 |
Volovitz I, Marmor Y, Azulay M, Machlenkin A, Goldberger O, Mor F, Slavin S, Ram Z, Cohen IR, Eisenbach L. Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 5452-62. PMID 21998458 DOI: 10.4049/Jimmunol.1003946 |
0.741 |
|
| 2009 |
Volovitz I, Mor F, Machlenkin A, Machlenkin A, Goldberger O, Marmor Y, Eisenbach L, Cohen IR, Cohen I. T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis. Immunology. 128: 92-102. PMID 19689739 DOI: 10.1111/J.1365-2567.2009.03074.X |
0.711 |
|
| 2008 |
Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, Eisenbach L. Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Research. 68: 3450-7. PMID 18451173 DOI: 10.1158/0008-5472.Can-07-5006 |
0.754 |
|
| 2007 |
Machlenkin A, Azriel-Rosenfeld R, Volovitz I, Vadai E, Lev A, Paz A, Goldberger O, Reiter Y, Tzehoval E, Benhar I, Eisenbach L. Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunology, Immunotherapy : Cii. 56: 217-26. PMID 16738849 DOI: 10.1007/S00262-006-0184-0 |
0.726 |
|
| 2005 |
Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier F, Tzehoval E, Eisenbach L. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy. Cancer Research. 65: 6435-42. PMID 16024648 DOI: 10.1158/0008-5472.Can-05-0133 |
0.717 |
|
| 2005 |
Machlenkin A, Goldberger O, Tirosh B, Paz A, Volovitz I, Bar-Haim E, Lee SH, Vadai E, Tzehoval E, Eisenbach L. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4955-61. PMID 16000595 DOI: 10.1158/1078-0432.Ccr-04-2422 |
0.737 |
|
| 2004 |
Lee SH, Bar-Haim E, Goldberger O, Reich-Zeliger S, Vadai E, Tzehoval E, Eisenbach L. Expression of FasL by tumor cells does not abrogate anti-tumor CTL function. Immunology Letters. 91: 119-26. PMID 15019279 DOI: 10.1016/J.Imlet.2003.10.010 |
0.695 |
|
| 2004 |
Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Therapy. 11: 237-48. PMID 14739939 DOI: 10.1038/Sj.Cgt.7700678 |
0.726 |
|
| Show low-probability matches. |